New breast cancer trial aims to wipe out tumors before surgery
NCT ID NCT06535893
First seen Nov 20, 2025 · Last updated Apr 24, 2026 · Updated 22 times
Summary
This study is for people with stage II or III breast cancer who will receive chemotherapy before surgery. It compares standard treatment with several experimental drug combinations to see which works better at eliminating all signs of cancer. About 100 participants will be enrolled. The goal is to improve the chance of a complete response, meaning no cancer remains in the breast or lymph nodes after treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nagoya City University
RECRUITINGNagoya, Aichi-ken, 467-8601, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.